Akèy › Kasinòm epitelyal ovè › Illinois › Chicago
Etid klinik pou Kasinòm epitelyal ovè nan Chicago, IL
7 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Ap rekriteFaz 2
- Rush Md Anderson Cancer Center /ID# 274926, Chicago
- University of Chicago Medical Center /ID# 274796, Chicago
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Ap rekriteFaz 3
- Research Site, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Ap rekriteFaz 1
- Context Investigational Site, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- University of Chicago Medical Center, Chicago
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Ap rekriteFaz 2
- University of Chicago Medical Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Ap rekriteFaz 1
- University of Chicago, Chicago
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Etid Kasinòm epitelyal ovè nan lòt vil
- Boston, MA8 etid
- Durham, NC8 etid
- San Diego, CA7 etid
- New York City, NY7 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- Houston, TX6 etid
- Cleveland, OH6 etid
- Portland, OR5 etid
- Los Angeles, CA5 etid
- Minneapolis, MN5 etid
- Edison, NJ5 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.